It means your body natural fat mobilization during a caloric deficit provides the substrate
At two or more years after starting treatment, the odds of a new diagnosis of alopecia in GLP-1 users were 37% higher than in users of so-called SGLT-2 drugs and 68% higher versus DPP-4 drugs, researchers at the University of Pennsylvania reported on Wednesday in The BMJ
Material in this article about reconstitution math, pharmacy procedure, and trial handling is provided for general understanding
The information presented in this course is intended solely for the use of healthcare professionals taking this course, for credit, from NCC
Reasons to track liver enzymes while on GLP-1s: Rapid fat mobilization during weight loss can temporarily affect liver function Pre-existing fatty liver may improve, and testing confirms progress Dehydration from reduced appetite can concentrate liver enzymes Combining GLP-1s with other medications increases liver processing demands Some individuals experience transient enzyme elevations that resolve with time If you're already monitoring pancreatic enzymes like amylase and lipase on GLP-1 therapy, adding liver markers gives you a complete picture of how your body is responding